construction projects - pilma · oceanside biopharmaceuticals p2 downstream (purification suite)...

2
Project Owner City State Years Project Value (in $ millions) Gilead Sciences Incorporated La Verne Grassroot Sterile Intravenous Therapeutics Plant La Verne CA 2015-2017 $500.0 Scripps Research Institute La Jolla Scripps Cardiovascular Institute Addition La Jolla CA 2011-2014 $456.0 Gilead Sciences Incorporated Foster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition Foster City CA 2016-2020 $300.0 HCP, Incorporated Life Sciences South San Francisco The Cove at Oyster Point R&D Buildings Phase III So. San Francisco CA 2017-2018 $220.0 Boehringer Ingelheim BioXcellence CMO Fremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/ Equip Upgrade Fremont CA 2017-2018 $217.0 Gilead Sciences Incorporated Foster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition Foster City CA 2013-2015 $200.0 Genentech (Roche USA) Incorporated Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit Oceanside CA 2015-2017 $180.0 HCP Incorporated South San Francisco Grassroot The Cove at Oyster Point R&D Buildings So. San Francisco CA 2015-2016 $170.0 HCP, Incorporated Life Sciences South San Francisco The Cove at Oyster Point R&D Buildings Phase II So. San Francisco CA 2016-2017 $160.0 Genentech (Roche USA) Incorporated Vacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning Vacaville CA 2013-2016 $153.0 Pharmaceutical & Biotech Manufacturing Number of Major Projects ($5+ million) 58 Major Project Valuation (Any major project active between 2012 and 2017) $4.85 billion Total Construction Spending (Capital and maintenance expenditure, 2012-17) $6.80 billion Major Projects ($5M+), 2012-17 Largest Construction Projects, Pharmaceutical and Biotech Manufacturing, 2012-2017 California Fact Sheet, 2012-17 California Construction Projects

Upload: others

Post on 03-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Construction Projects - PILMA · Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit Oceanside CA 2015-2017 $180.0 HCP Incorporated South San Francisco Grassroot

Project Owner City State Years Project Value (in $ millions)

Gilead Sciences IncorporatedLa Verne Grassroot Sterile Intravenous Therapeutics Plant La Verne CA 2015-2017 $500.0

Scripps Research InstituteLa Jolla Scripps Cardiovascular Institute Addition La Jolla CA 2011-2014 $456.0

Gilead Sciences IncorporatedFoster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition Foster City CA 2016-2020 $300.0

HCP, Incorporated Life SciencesSouth San Francisco The Cove at Oyster Point R&D Buildings Phase III

So. San Francisco CA 2017-2018 $220.0

Boehringer Ingelheim BioXcellence CMOFremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/ Equip Upgrade

Fremont CA 2017-2018 $217.0

Gilead Sciences IncorporatedFoster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition

Foster City CA 2013-2015 $200.0

Genentech (Roche USA) IncorporatedOceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit Oceanside CA 2015-2017 $180.0

HCP IncorporatedSouth San Francisco Grassroot The Cove at Oyster Point R&D Buildings

So. San Francisco CA 2015-2016 $170.0

HCP, Incorporated Life SciencesSouth San Francisco The Cove at Oyster Point R&D Buildings Phase II

So. San Francisco CA 2016-2017 $160.0

Genentech (Roche USA) IncorporatedVacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning Vacaville CA 2013-2016 $153.0

Pharmaceutical & Biotech Manufacturing

Number of Major Projects ($5+ million)

58

Major Project Valuation (Any major project active between 2012 and 2017)

$4.85 billion

Total Construction Spending (Capital and maintenance expenditure, 2012-17)

$6.80 billion

Major Projects ($5M+), 2012-17

Largest Construction Projects, Pharmaceutical and Biotech Manufacturing, 2012-2017

California Fact Sheet, 2012-17

CaliforniaConstruction Projects

Page 2: Construction Projects - PILMA · Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit Oceanside CA 2015-2017 $180.0 HCP Incorporated South San Francisco Grassroot

California Construction Labor Hours by Trade, Pharmaceutical & Biotech, 2012-17

Installation Maintenance Total

Boilermaker 110,575 58,476 169,051

Carpenter 470,719 476,300 947,020

Electrician 2,757,704 1,598,672 4,356,376

HVAC Installers 279,222 27,349 306,571

Instrumentation Tech

1,665,724 580,285 2,246,009

Insulator 245,573 140,296 385,870

Ironworker 239,800 459,795 699,595

Laborer 523,164 178,966 702,131

Millwright 381,904 528,175 910,079

Operator 602,609 134,637 737,247

Painting 87,039 132,751 219,790

Plumber + Pipefitter

1,150,154 169,770 1,319,924

Scaffolding 199,390 92,431 291,820

Welder 170,081 323,035 493,116

8,883,658 4,900,940 13,784,599

La Verne, CA – Gilead Sciences Incorporated, La Verne Grassroot Sterile Intravenous Therapeutics Plant ($500 million construction in 2015-17)

Union Labor & Earnings, 2012-17

Pharmaceutical & Biotech

Labor Hours Demanded(14 trades, installation and maintenance)

13.8 million

Union Labor Hours (est.)(State union % in non-residential = 34.8%)

4.8 million

Average Union Wage(Union construction workers, 2017 dollars)

$28.47

Total Union Earnings (est.)(Union hours times average wage)

$136.7 million

Industry Analysis: California

Pharmaceutical Manufacturing (2017) (NAICS = 325400)

Firms .................................................................................581Employees ...............................................................52,125Annual Wages .............................................$7.7 billion

Data Sources:Pharmaceutical and biotech industry data (projects, spending, labor hours demanded) from Industrial Information Resources (IIR). Average hourly wage for union construction workers from the Current Population Survey. State industry employment data from the Bureau of Labor Statistics (QCEW) using the North American Industry Classification System (NAICS). Note: Pharmaceutical manufacturing industry statistics (above) do not represent the entirety of the pharmaceutical and biotech industry featured in this study. Most significantly, in addition to NAICS 325400 (“Pharmaceutical Manufacturing”), other industry jobs comprise a subset of NAICS 541700 (“Scientific R&D Services”). Photo credit: US Geological Survey.

Photo credit: US Geological Survey.

CaliforniaConstruction Employment